Editor's note: This column originally ran in the Detroit Free Press on April 11, 1986. Chet Lemon died on May 8, 2025. A note from Mitch: I was deeply saddened to learn of the passing of Chet Lemon.

Another notable valuation metric for EXEL is its P/B ratio of 4.70. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus ...

ALAMEDA, Calif., May 22, 2025--Exelixis, Inc. (Nasdaq: EXEL) today announced results from an expansion cohort of the phase 1b/2 STELLAR-002 trial evaluating zanzalintinib in combination with ...

CLERMONT, Fla. — In a stroke rehab center, past the security desk, down a wide hallway, inside a private room, Chet Lemon sits next to his bed strapped into a wheelchair. He wears a yellow ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis (EXEL) or argenex SE (ARGX). But which of these two stocks presents investors ...